A Phase III, Multicenter, Randomized, Placebo-Controlled Study of Atezolizumab (Anti-PD-L1 Antibody) as Monotherapy and in Combination With Platinum-Based Chemotherapy in Patients With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009333/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
A Phase III, randomised study of atezolizumab alone and in combination with chemotherapy
versus chemotherapy alone in participants with untreated advanced urothelial cancer.
提供机构：
Vivli
创建时间：
2023-10-05
